TwinStrand Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- TwinStrand Biosciences's estimated annual revenue is currently $11.9M per year.
- TwinStrand Biosciences's estimated revenue per employee is $155,000
- TwinStrand Biosciences's total funding is $73.2M.
Employee Data
- TwinStrand Biosciences has 77 Employees.
- TwinStrand Biosciences grew their employee count by -30% last year.
TwinStrand Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP, Intellectual Property & Corporate Strategy | Reveal Email/Phone |
3 | VP, Commercial | Reveal Email/Phone |
4 | Head Procurement | Reveal Email/Phone |
5 | Associate Director Scientific Operations | Reveal Email/Phone |
6 | Associate Director Market Development | Reveal Email/Phone |
7 | Associate Director, Global Commercial Operations | Reveal Email/Phone |
8 | Associate Director Marketing Communications | Reveal Email/Phone |
9 | Director, Quality, Manufacturing & Supply Chain | Reveal Email/Phone |
10 | Director Production Bioinformatics | Reveal Email/Phone |
TwinStrand Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is TwinStrand Biosciences?
At TwinStrand Biosciences we are using Duplex Sequencing ￃﾢ￢ﾀﾞￂﾢ Technology to detect ultra-rare variants that are invisible by other sequencing approaches. We are applying our technology to a new generation of high-accuracy clinical diagnostics and innovative tools for scientific discovery.
keywords:N/A
$73.2M
Total Funding
77
Number of Employees
$11.9M
Revenue (est)
-30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TwinStrand Biosciences News
TwinStrand Biosciences Expands Executive Team With Appointment of Goran Pljevaljcic as Chief Commercial Officer. Published: Apr 28, 2022. April 28...
... CEO and cofounder of TwinStrand Biosciences, said via email. He added that TwinStrand, which has commercialized duplex sequencing,...
TwinStrand Biosciences, a genomics startup developing technology to identify ultra-low frequency DNA mutations, has raised a $50 million Series B led by Section 32. New investors Soleus Capital and Janus Henderson Investors, as well as existing backers Madrona Venture Group, Ridgeback Capital an ...
TwinStrand Biosciences, the pioneer and developer of Duplex Sequencing, an ultra-high accuracy technology for revealing exceptionally low-frequency genetic variants, today announced that it has closed a $50 million Series B financing led by Section 32, with participation from new investors Soleu ...
Jesse Salk, CEO and co-founder of TwinStrand Biosciences. (TwinStrand Photo) New funding: Gene-sequencing startup TwinStrand Biosciences raised $50 million in a Series B round led by Section 32, a California-based fund focused on biotech, technology, healthcare and life sciences. Total venture ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.9M | 77 | 7% | N/A |
#2 | $15.8M | 77 | 8% | N/A |
#3 | $27M | 77 | 1% | $13.4M |
#4 | $17.5M | 77 | 22% | $15M |
#5 | $11.9M | 77 | -7% | $16.3M |